Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
Conditions:   Idiopathic Inflammatory Myopathies;   Osteoporosis, Osteopenia Interventions:   Drug: Denosumab;   Drug: Zoledronic Acid Sponsors:   Kwong Wah Hospital;   Tung Wah Group of Hospitals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2019 Category: Research Source Type: clinical trials

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
Condition:   Carcinoma, Non-Small-Cell Lung Interventions:   Biological: Tyrosine Kinase Inhibitor;   Drug: Zoledronic Acid 4 MG/100 ML Intravenous Solution [ZOMETA];   Drug: Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA] Sponsors:   University of Colorado, Denver;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2019 Category: Research Source Type: clinical trials

Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOl édronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases
Condition:   Vertebral Metastasis Interventions:   Combination Product: Zoledronic Acid 4Mg Solution for Injection + Hypo-fractured radiotherapy in stereotactic conditions;   Radiation: Hypo-fractured radiotherapy in stereotactic conditions Sponsor:   Institut Cancerologie de l'Ouest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2019 Category: Research Source Type: clinical trials

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma
Conditions:   Lung Metastases;   Tumor Necrosis Intervention:   Drug: Zoledronic Acid Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials

Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men
Condition:   Secondary Osteoporosis Interventions:   Drug: Colaren in HIV positive;   Drug: standard treatment in HIV positive;   Drug: Colaren in HIV negative;   Drug: standard treatment in HIV negative Sponsors:   University of Guadalajara;   Hospital Civil de Guadalajara Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2019 Category: Research Source Type: clinical trials